Intrua Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Sell
19,442
-1,618
-8% -$92.9K 0.1% 147
2026
Q1
$1.28M Sell
21,060
-10
-0% -$583 0.13% 122
2025
Q4
$1.14M Buy
21,070
+1,788
+9% +$86K 0.12% 134
2025
Q3
$870K Buy
19,282
+544
+3% +$25.4K 0.09% 171
2025
Q2
$867K Sell
18,738
-3,878
-17% -$190K 0.12% 131
2025
Q1
$1.38M Buy
22,616
+4,652
+26% +$271K 0.2% 88
2024
Q4
$1.02M Sell
17,964
-356
-2% -$19.9K 0.16% 108
2024
Q3
$948K Sell
18,320
-1,597
-8% -$74.9K 0.14% 127
2024
Q2
$827K Buy
19,917
+4,315
+28% +$193K 0.12% 145
2024
Q1
$846K Buy
15,602
+4,522
+41% +$230K 0.12% 157
2023
Q4
$569K Buy
11,080
+2,677
+32% +$141K 0.08% 204
2023
Q3
$488K Buy
8,403
+819
+11% +$50.2K 0.08% 198
2023
Q2
$485K Buy
7,584
+2,124
+39% +$142K 0.08% 201
2023
Q1
$372K Buy
5,460
+865
+19% +$61K 0.08% 219
2022
Q4
$339K Sell
4,595
-753
-14% -$56.8K 0.08% 235
2022
Q3
$380K Sell
5,348
-692
-11% -$50.2K 0.1% 200
2022
Q2
$465K Sell
6,040
-2,692
-31% -$205K 0.1% 216
2022
Q1
$638K Sell
8,732
-1,346
-13% -$90.4K 0.11% 187
2021
Q4
$628K Buy
10,078
+723
+8% +$42.4K 0.11% 185
2021
Q3
$528K Buy
+9,355
New +$616K 0.1% 202
2021
Q2
Sell
-3,226
Closed -$213K 297
2021
Q1
$213K Buy
+3,226
New +$201K 0.05% 273

Other funds holding BMY

Intrua Financial's BMY Position: Q2 2026 in Review

Intrua Financial reduced its Bristol-Myers Squibb (BMY) stake by 7.7% in Q2 2026, selling an estimated $92.9K and leaving 19,442 shares worth $1.12M. The position accounts for 0.1% of the portfolio, ranked #147.

Intrua Financial first reported a position in BMY in Q1 2021 and has held it in 21 quarters since. The position peaked at $1.38M in Q1 2025. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Intrua Financial held 19,442 shares of Bristol-Myers Squibb worth $1.12M as of Q2 2026.
  • Intrua Financial sold 1,618 Bristol-Myers Squibb shares in Q2 2026, an estimated $92.9K.
  • Bristol-Myers Squibb made up 0.1% of Intrua Financial's portfolio in Q2 2026, its #147 holding.
  • Intrua Financial first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 21 quarters since.
  • Intrua Financial's Bristol-Myers Squibb position peaked at $1.38M in Q1 2025.
  • 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Intrua Financial's 13F filing for Q2 2026, filed 24 Jul 2026.